(Exact name of registrant as specified in its charter) | ||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | |||||||
(Address of principal executive offices) | (Zip Code) | |||||||
( | ||||||||
(Registrant's telephone number, including the area code) | ||||||||
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
Accelerated filer ☐ | ||||||||||||||
Non-accelerated filer ☐ | Smaller reporting company | Emerging growth company |
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands, except per share amounts) | |||||||||||
Revenue | $ | $ | |||||||||
Cost of revenue | |||||||||||
Gross profit | |||||||||||
Selling, general, and administrative expenses | |||||||||||
Amortization of intangible assets | |||||||||||
Operating income | |||||||||||
Interest expense | ( | ( | |||||||||
Other expense, net | ( | ( | |||||||||
Income before income taxes | |||||||||||
Provision for income taxes | |||||||||||
Net income | $ | $ | |||||||||
Earnings per share: | |||||||||||
Basic | $ | $ | |||||||||
Diluted | $ | $ | |||||||||
Weighted average shares outstanding: | |||||||||||
Basic | |||||||||||
Diluted | |||||||||||
Dividends declared per share | $ | $ |
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Net income | $ | $ | |||||||||
Other comprehensive income, net of tax: | |||||||||||
Foreign currency translation adjustments | |||||||||||
Net gains on cash flow hedge, net of tax | |||||||||||
Other comprehensive income | |||||||||||
Comprehensive income | $ | $ |
December 31, 2021 | September 30, 2021 | ||||||||||
(unaudited) | |||||||||||
(in thousands) | |||||||||||
Assets: | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Accounts receivable, net | |||||||||||
Income taxes receivable | |||||||||||
Prepaid expenses and other current assets | |||||||||||
Total current assets | |||||||||||
Property and equipment, net | |||||||||||
Capitalized software, net | |||||||||||
Operating lease right-of-use assets | |||||||||||
Goodwill | |||||||||||
Intangible assets, net | |||||||||||
Deferred contract costs, net | |||||||||||
Deferred compensation plan assets | |||||||||||
Deferred income taxes | |||||||||||
Other assets | |||||||||||
Total assets | $ | $ | |||||||||
Liabilities and Shareholders' Equity: | |||||||||||
Liabilities: | |||||||||||
Accounts payable and accrued liabilities | $ | $ | |||||||||
Accrued compensation and benefits | |||||||||||
Deferred revenue, current portion | |||||||||||
Income taxes payable | |||||||||||
Long-term debt, current portion | |||||||||||
Operating lease liabilities, current portion | |||||||||||
Other current liabilities | |||||||||||
Total current liabilities | |||||||||||
Deferred revenue, non-current portion | |||||||||||
Deferred income taxes | |||||||||||
Long-term debt, non-current portion | |||||||||||
Deferred compensation plan liabilities, non-current portion | |||||||||||
Operating lease liabilities, non-current portion | |||||||||||
Other liabilities | |||||||||||
Total liabilities | |||||||||||
Commitments and contingencies (Note 14) | |||||||||||
Shareholders' equity: | |||||||||||
Common stock, no par value; | |||||||||||
Accumulated other comprehensive loss | ( | ( | |||||||||
Retained earnings | |||||||||||
Total shareholders' equity | |||||||||||
Total liabilities and shareholders' equity | $ | $ |
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Cash flows from operating activities: | |||||||||||
Net income | $ | $ | |||||||||
Adjustments to reconcile net income to cash flows from operating activities: | |||||||||||
Depreciation and amortization of property, equipment and capitalized software | |||||||||||
Amortization of intangible assets | |||||||||||
Amortization of debt issuance costs and debt discount | |||||||||||
Deferred income taxes | ( | ||||||||||
Stock compensation expense | |||||||||||
Change in assets and liabilities, net of effects of business combinations: | |||||||||||
Accounts receivable | ( | ||||||||||
Prepaid expenses and other current assets | ( | ||||||||||
Deferred contract costs | ( | ( | |||||||||
Accounts payable and accrued liabilities | ( | ||||||||||
Accrued compensation and benefits | ( | ( | |||||||||
Deferred revenue | |||||||||||
Income taxes | |||||||||||
Operating lease right-of-use assets and liabilities | ( | ( | |||||||||
Other assets and liabilities | |||||||||||
Net cash (used in)/provided by operating activities | ( | ||||||||||
Cash flows from investing activities: | |||||||||||
Purchases of property and equipment and capitalized software | ( | ( | |||||||||
Other | ( | ||||||||||
Net cash used in investing activities | ( | ( | |||||||||
Cash flows from financing activities: | |||||||||||
Cash dividends paid to Maximus shareholders | ( | ( | |||||||||
Purchases of Maximus common stock | ( | ( | |||||||||
Tax withholding related to RSU vesting | ( | ( | |||||||||
Proceeds from borrowings | |||||||||||
Principal payments for debt | ( | ( | |||||||||
Other | ( | ||||||||||
Net cash provided by/(used in) financing activities | ( | ||||||||||
Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||||||||
Net change in cash, cash equivalents, and restricted cash | |||||||||||
Cash, cash equivalents and restricted cash, beginning of period | |||||||||||
Cash, cash equivalents and restricted cash, end of period | $ | $ |
Common Stock | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity | ||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||
Balance at September 30, 2021 | $ | $ | ( | $ | $ | ||||||||||||||||||||||||
Net income | — | — | — | ||||||||||||||||||||||||||
Foreign currency translation | — | — | — | ||||||||||||||||||||||||||
Cash flow hedge, net of tax | — | — | — | ||||||||||||||||||||||||||
Cash dividends | — | — | — | ( | ( | ||||||||||||||||||||||||
Dividends on RSUs | — | — | ( | ||||||||||||||||||||||||||
Purchases of Maximus common stock | ( | — | — | ( | ( | ||||||||||||||||||||||||
Stock compensation expense | — | — | — | ||||||||||||||||||||||||||
Tax withholding adjustment related to RSU vesting | — | — | — | ||||||||||||||||||||||||||
Balance as of December 31, 2021 | $ | $ | ( | $ | $ |
Common Stock | Accumulated Other Comprehensive Loss | Retained Earnings | Total Equity | ||||||||||||||||||||||||||
Shares | Amount | ||||||||||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||||||||
Balance at September 30, 2020 | $ | $ | ( | $ | $ | ||||||||||||||||||||||||
Net income | — | — | — | ||||||||||||||||||||||||||
Foreign currency translation | — | — | — | ||||||||||||||||||||||||||
Cash dividends | — | — | — | ( | ( | ||||||||||||||||||||||||
Dividends on RSUs | — | — | ( | ||||||||||||||||||||||||||
Purchases of Maximus common stock | ( | — | — | ( | ( | ||||||||||||||||||||||||
Stock compensation expense | — | — | — | ||||||||||||||||||||||||||
Balance as of December 31, 2020 | $ | $ | ( | $ | $ |
Table 3: Results of Operation by Business Segment (1) | |||||||||||||||||||||||
For the Three Months Ended | |||||||||||||||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||||||||||||||
Amount | % (2) | Amount | % (2) | ||||||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||
Revenue: | |||||||||||||||||||||||
U.S. Services | $ | $ | |||||||||||||||||||||
U.S. Federal Services | |||||||||||||||||||||||
Outside the U.S. | |||||||||||||||||||||||
Revenue | $ | $ | |||||||||||||||||||||
Gross profit: | |||||||||||||||||||||||
U.S. Services | $ | $ | |||||||||||||||||||||
U.S. Federal Services | |||||||||||||||||||||||
Outside the U.S. | |||||||||||||||||||||||
Gross profit | $ | $ | |||||||||||||||||||||
Selling, general, and administrative expenses: | |||||||||||||||||||||||
U.S. Services | $ | $ | |||||||||||||||||||||
U.S. Federal Services | |||||||||||||||||||||||
Outside the U.S. | |||||||||||||||||||||||
Other (3) | NM | NM | |||||||||||||||||||||
Selling, general, and administrative expenses | $ | $ | |||||||||||||||||||||
Operating income: | |||||||||||||||||||||||
U.S. Services | $ | $ | |||||||||||||||||||||
U.S. Federal Services | |||||||||||||||||||||||
Outside the U.S. | ( | ( | |||||||||||||||||||||
Amortization of intangible assets | ( | NM | ( | NM | |||||||||||||||||||
Other (3) | ( | NM | ( | NM | |||||||||||||||||||
Operating income | $ | $ |
Table 4.1: Revenue by Contract Type | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Performance-based | $ | $ | |||||||||
Cost-plus | |||||||||||
Fixed price | |||||||||||
Time and materials | |||||||||||
Total revenue | $ | $ |
Table 4.2: Revenue by Customer Type | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
U.S. state government agencies | $ | $ | |||||||||
United States Federal Government agencies | |||||||||||
International government agencies | |||||||||||
Other, including local municipalities and commercial customers | |||||||||||
Total revenue | $ | $ |
Table 4.3: Revenue by Geography | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
United States | $ | $ | |||||||||
United Kingdom | |||||||||||
Australia | |||||||||||
Rest of world | |||||||||||
Total revenue | $ | $ |
Table 5: Weighted Average Number of Shares - Earnings Per Share | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Basic weighted average shares outstanding | |||||||||||
Dilutive effect of unvested RSUs and PSUs | |||||||||||
Denominator for diluted earnings per share |
Table 6.1: VES Valuation | |||||||||||||||||
Allocation of Assets and Liabilities as of September 30, 2021 | Adjustments | Estimated Allocation of Assets and Liabilities as of December 31, 2021 | |||||||||||||||
(in thousands) | |||||||||||||||||
Consideration paid: | |||||||||||||||||
Cash consideration paid, net of cash acquired | $ | $ | $ | ||||||||||||||
Estimated additional cash payments | |||||||||||||||||
Estimated cash consideration, net of cash acquired | |||||||||||||||||
Assets acquired: | |||||||||||||||||
Accounts receivable - billed, billable and unbilled | $ | $ | $ | ||||||||||||||
Prepaid expenses and other current assets | |||||||||||||||||
Property and equipment, net | ( | ||||||||||||||||
Operating lease right-of-use assets | |||||||||||||||||
Intangible assets | |||||||||||||||||
Other assets | |||||||||||||||||
Total identifiable assets acquired | ( | ||||||||||||||||
Liabilities assumed: | |||||||||||||||||
Accounts payable and accrued compensation | |||||||||||||||||
Operating lease liabilities | |||||||||||||||||
Income taxes payable, current | |||||||||||||||||
Deferred income taxes | |||||||||||||||||
Other long-term liabilities | |||||||||||||||||
Total identifiable liabilities assumed | |||||||||||||||||
Net identifiable assets acquired | ( | ||||||||||||||||
Goodwill | |||||||||||||||||
Net assets acquired | $ | $ | $ |
Table 6.2: VES Intangible Asset Values and Useful Lives | |||||||||||
Estimated Straight-Line Useful Life | Estimated Fair Value | ||||||||||
(in thousands) | |||||||||||
Customer contracts and relationships | $ | ||||||||||
Provider network | |||||||||||
Technology-based intangible assets | |||||||||||
Total intangible assets | $ |
Table 7.1: Details of Debt | |||||||||||
December 31, 2021 | September 30, 2021 | ||||||||||
(in thousands) | |||||||||||
Term Loan A, due 2026 | $ | $ | |||||||||
Term Loan B, due 2028 | |||||||||||
Subsidiary loan agreements | |||||||||||
Revolver | |||||||||||
Total debt principal | |||||||||||
Less: Unamortized debt-issuance costs and discounts | ( | ( | |||||||||
Total debt | |||||||||||
Less: Current portion of long-term debt | ( | ( | |||||||||
Long-term debt | $ | $ |
Table 7.2: Details of Future Minimum Principal Payments Due | |||||
Amount Due | |||||
(in thousands) | |||||
January 1, 2022 through September 30, 2022 | $ | ||||
Year ended September 30, 2023 | |||||
Year ended September 30, 2024 | |||||
Year ended September 30, 2025 | |||||
Year ended September 30, 2026 | |||||
Thereafter | |||||
Total payments | $ |
Table 8.1: Details of Derivatives Fair Value | |||||||||||
December 31, 2021 | September 30, 2021 | ||||||||||
(in thousands) | |||||||||||
Assets: | |||||||||||
Interest rate swap | $ | $ | |||||||||
Total assets | $ | $ | |||||||||
Liabilities: | |||||||||||
Interest rate swap | $ | $ | |||||||||
Total liabilities | $ | $ |
Table 8.2: Gains on Derivatives | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Net gains recognized in AOCI on derivatives, net of tax (1) | $ | $ | |||||||||
Amounts reclassified to earnings from accumulated other comprehensive loss (2) | |||||||||||
Net current period other comprehensive income | $ | $ |
Table 9: Fair Value | |||||||||||||||||||||||
As of December 31, 2021 | |||||||||||||||||||||||
Level 1 | Level 2 | Level 3 | Balance | ||||||||||||||||||||
(in thousands) | |||||||||||||||||||||||
Assets: | |||||||||||||||||||||||
Deferred compensation assets - Rabbi Trust | $ | $ | $ | $ | |||||||||||||||||||
Interest rate swap | |||||||||||||||||||||||
Total assets | $ | $ | $ | $ | |||||||||||||||||||
Liabilities: | |||||||||||||||||||||||
Contingent consideration | $ | $ | $ | $ | |||||||||||||||||||
Total liabilities | $ | $ | $ | $ |
Table 10: Details of Changes in Accumulated Other Comprehensive Loss by Category | |||||||||||||||||
Foreign currency translation adjustment | Net unrealized (loss)/gain on derivatives, net of tax | Total | |||||||||||||||
(in thousands) | |||||||||||||||||
Balance as of September 30, 2021 | $ | ( | $ | ( | $ | ( | |||||||||||
Other comprehensive income before reclassifications | |||||||||||||||||
Amounts reclassified from accumulated other comprehensive loss | |||||||||||||||||
Net current period other comprehensive income | |||||||||||||||||
Balance as of December 31, 2021 | $ | ( | $ | $ | ( |
Table 11.1: Details of Cash and Cash Equivalents and Restricted Cash | |||||||||||
December 31, 2021 | September 30, 2021 | ||||||||||
(in thousands) | |||||||||||
Cash and cash equivalents | $ | $ | |||||||||
Restricted cash (1) | |||||||||||
Cash, cash equivalents, and restricted cash | $ | $ |
Table 11.2: Supplemental Disclosures of Cash Flow Information | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Interest payments | $ | $ | |||||||||
Income tax payments |
Table 12: Details of Accounts Receivable, Net | |||||||||||
December 31, 2021 | September 30, 2021 | ||||||||||
(in thousands) | |||||||||||
Billed and billable receivables | $ | $ | |||||||||
Unbilled receivables | |||||||||||
Allowance for credit losses | ( | ( | |||||||||
Accounts receivable, net | $ | $ |
Table 13: Details of Property and Equipment, Net | |||||||||||
December 31, 2021 | September 30, 2021 | ||||||||||
(in thousands) | |||||||||||
Land | $ | $ | |||||||||
Building and improvements | |||||||||||
Office furniture and equipment | |||||||||||
Leasehold improvements | |||||||||||
Property and equipment, at cost | |||||||||||
Accumulated depreciation | ( | ( | |||||||||
Property and equipment, net | $ | $ |
Table MD&A 1: Consolidated Results of Operations | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(dollars in thousands, except per share data) | |||||||||||
Revenue | $ | 1,150,876 | $ | 945,554 | |||||||
Cost of revenue | 922,721 | 739,499 | |||||||||
Gross profit | 228,155 | 206,055 | |||||||||
Gross profit percentage | 19.8 % | 21.8 % | |||||||||
Selling, general, and administrative expenses | 124,221 | 111,967 | |||||||||
Selling, general, and administrative expenses as a percentage of revenue | 10.8 % | 11.8 % | |||||||||
Amortization of intangible assets | 22,405 | 6,516 | |||||||||
Operating income | 81,529 | 87,572 | |||||||||
Operating income margin | 7.1 % | 9.3 % | |||||||||
Interest expense | (9,638) | (206) | |||||||||
Other expense, net | (311) | (775) | |||||||||
Income before income taxes | 71,580 | 86,591 | |||||||||
Provision for income taxes | 18,250 | 22,514 | |||||||||
Effective tax rate | 25.5 % | 26.0 % | |||||||||
Net income | $ | 53,330 | $ | 64,077 | |||||||
Earnings per share: | |||||||||||
Basic | $ | 0.86 | $ | 1.03 | |||||||
Diluted | $ | 0.85 | $ | 1.03 |
Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended December 31, 2021 | |||||||||||||||||||||||||||||||||||
Revenue | Cost of Revenue | Gross Profit | |||||||||||||||||||||||||||||||||
Dollars | % Change | Dollars | % Change | Dollars | % Change | ||||||||||||||||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||||||||||||||
Three Months Ended December 31, 2020 | $ | 945,554 | $ | 739,499 | $ | 206,055 | |||||||||||||||||||||||||||||
Organic effect | (32,764) | (3.5) | % | 10,844 | 1.5 | % | (43,608) | (21.2) | % | ||||||||||||||||||||||||||
Acquired growth | 235,766 | 24.9 | % | 170,187 | 23.0 | % | 65,579 | 31.8 | % | ||||||||||||||||||||||||||
Currency effect compared to the prior period | 2,320 | 0.2 | % | 2,191 | 0.3 | % | 129 | 0.1 | % | ||||||||||||||||||||||||||
Three Months Ended December 31, 2021 | $ | 1,150,876 | 21.7 | % | $ | 922,721 | 24.8 | % | $ | 228,155 | 10.7 | % |
Table MD&A 3: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(dollars in thousands, except per share data) | |||||||||||
Operating income | $ | 81,529 | $ | 87,572 | |||||||
Add back: Amortization of intangible assets | 22,405 | 6,516 | |||||||||
Adjusted operating income excluding amortization of intangible assets (Non-GAAP) | $ | 103,934 | $ | 94,088 | |||||||
Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP) | 9.0 | % | 10.0 | % | |||||||
Net income | $ | 53,330 | $ | 64,077 | |||||||
Add back: Amortization of intangible assets, net of tax | 16,530 | 4,822 | |||||||||
Adjusted net income excluding amortization of intangible assets (Non-GAAP) | $ | 69,860 | $ | 68,899 | |||||||
Diluted earnings per share | $ | 0.85 | $ | 1.03 | |||||||
Add back: Effect of amortization of intangible assets on diluted earnings per share | 0.27 | 0.08 | |||||||||
Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP) | $ | 1.12 | $ | 1.11 |
Table MD&A 4: U.S. Services Segment - Financial Results | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(dollars in thousands) | |||||||||||
Revenue | $ | 386,417 | $ | 384,934 | |||||||
Cost of revenue | 296,718 | 285,932 | |||||||||
Gross profit | 89,699 | 99,002 | |||||||||
Selling, general, and administrative expenses | 35,102 | 37,456 | |||||||||
Operating income | 54,597 | 61,546 | |||||||||
Gross profit percentage | 23.2 | % | 25.7 | % | |||||||
Operating margin percentage | 14.1 | % | 16.0 | % |
Table MD&A 5: U.S. Federal Services Segment - Financial Results | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(dollars in thousands) | |||||||||||
Revenue | $ | 581,871 | $ | 405,245 | |||||||
Cost of revenue | 455,295 | 322,749 | |||||||||
Gross profit | 126,576 | 82,496 | |||||||||
Selling, general, and administrative expenses | 64,925 | 52,252 | |||||||||
Operating income | 61,651 | 30,244 | |||||||||
Gross profit percentage | 21.8 | % | 20.4 | % | |||||||
Operating margin percentage | 10.6 | % | 7.5 | % |
Table MD&A 6: U.S. Federal Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit | |||||||||||||||||||||||||||||||||||
Revenue | Cost of Revenue | Gross Profit | |||||||||||||||||||||||||||||||||
Amount | % Change | Amount | % Change | Amount | % Change | ||||||||||||||||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||||||||||||||
Three Months Ended December 31, 2020 | $ | 405,245 | $ | 322,749 | $ | 82,496 | |||||||||||||||||||||||||||||
Organic effect | (53,339) | (13.2) | % | (34,064) | (10.6) | % | (19,275) | (23.4) | % | ||||||||||||||||||||||||||
Acquired growth | 229,965 | 56.7 | % | 166,610 | 51.6 | % | 63,355 | 76.8 | % | ||||||||||||||||||||||||||
Three Months Ended December 31, 2021 | $ | 581,871 | 43.6 | % | $ | 455,295 | 41.1 | % | $ | 126,576 | 53.4 | % |
Table MD&A 7: Outside the U.S. Segment - Financial Results | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(dollars in thousands) | |||||||||||
Revenue | $ | 182,588 | $ | 155,375 | |||||||
Cost of revenue | 170,708 | 130,818 | |||||||||
Gross profit | 11,880 | 24,557 | |||||||||
Selling, general, and administrative expenses | 21,340 | 20,032 | |||||||||
Operating (loss)/income | (9,460) | 4,525 | |||||||||
Gross profit percentage | 6.5 | % | 15.8 | % | |||||||
Operating margin percentage | (5.2) | % | 2.9 | % |
Table MD&A 8: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit | |||||||||||||||||||||||||||||||||||
Revenue | Cost of Revenue | Gross Profit | |||||||||||||||||||||||||||||||||
Amount | % Change | Amount | % Change | Amount | % Change | ||||||||||||||||||||||||||||||
(dollars in thousands) | |||||||||||||||||||||||||||||||||||
Three Months Ended December 31, 2020 | $ | 155,375 | $ | 130,818 | $ | 24,557 | |||||||||||||||||||||||||||||
Organic effect | 19,092 | 12.3 | % | 34,122 | 26.1 | % | (15,030) | (61.2) | % | ||||||||||||||||||||||||||
Acquired growth | 5,801 | 3.7 | % | 3,577 | 2.7 | % | 2,224 | 9.1 | % | ||||||||||||||||||||||||||
Currency effect compared to the prior period | 2,320 | 1.5 | % | 2,191 | 1.7 | % | 129 | 0.5 | % | ||||||||||||||||||||||||||
Three Months Ended December 31, 2021 | $ | 182,588 | 17.5 | % | $ | 170,708 | 30.5 | % | $ | 11,880 | (51.6) | % |
Table MD&A 10: Net Change in Cash and Cash Equivalents and Restricted Cash | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Operating activities: | |||||||||||
Net income | $ | 53,330 | $ | 64,077 | |||||||
Non-cash adjustments | 42,438 | 25,693 | |||||||||
Changes in working capital | (98,687) | 8,345 | |||||||||
Net cash (used in)/provided by operating activities | (2,919) | 98,115 | |||||||||
Net cash used in investing activities | (6,327) | (9,253) | |||||||||
Net cash provided by/(used in) financing activities | 54,916 | (31,487) | |||||||||
Effect of foreign exchange rates on cash and cash equivalents and restricted cash | 372 | 3,882 | |||||||||
Net change in cash and cash equivalents and restricted cash | $ | 46,042 | $ | 61,257 |
Table MD&A 11: Free Cash Flow (Non-GAAP) | |||||||||||
For the Three Months Ended | |||||||||||
December 31, 2021 | December 31, 2020 | ||||||||||
(in thousands) | |||||||||||
Net cash (used in)/provided by operating activities | $ | (2,919) | $ | 98,115 | |||||||
Purchases of property and equipment and capitalized software | (6,327) | (9,094) | |||||||||
Free cash flow (Non-GAAP) | $ | (9,246) | $ | 89,021 |
Table MD&A 12: Reconciliation of Net Income to Non-GAAP Adjusted EBITA, Non-GAAP Adjusted EBITDA, and Non-GAAP Pro Forma Adjusted EBITDA | |||||||||||
For the Three Months Ended | For the Trailing Twelve Months Ended | ||||||||||
December 31, 2021 | December 31, 2021 | ||||||||||
(in thousands) | |||||||||||
Net income | $ | 53,330 | $ | 280,453 | |||||||
Adjustments: | |||||||||||
Interest expense | 9,638 | 24,176 | |||||||||
Other expense, net | 311 | 9,641 | |||||||||
Provision for income taxes | 18,250 | 88,216 | |||||||||
Amortization of intangibles | 22,405 | 60,247 | |||||||||
Stock compensation expense | 8,248 | 30,741 | |||||||||
Acquisition-related expenses | 2,490 | 12,661 | |||||||||
Adjusted EBITA - Non-GAAP measure | 114,672 | 506,135 | |||||||||
Depreciation and amortization of property, equipment, and capitalized software | 11,365 | 45,909 | |||||||||
Adjusted EBITDA - Non-GAAP measure | $ | 126,037 | $ | 552,044 | |||||||
Pro forma adjusted EBITDA related to acquisitions - Non-GAAP measure | 75,031 | ||||||||||
Pro forma adjusted EBITDA - Non-GAAP measure | $ | 627,075 |
Common Stock Repurchase Activity During the Three Months Ended December 31, 2021 | ||||||||||||||||||||||||||
Period | Total Number of Shares Purchased | Average Price Paid Per Share | Total Number of Shares Purchased as Part of the Publicly Announced Plans or Programs | Maximum Dollar Value that May Yet Be Purchased Under the Plans or Programs | ||||||||||||||||||||||
(dollars in thousands, except per share data) | ||||||||||||||||||||||||||
October 1 - October 31, 2021 | — | $ | — | — | $ | 146,665 | ||||||||||||||||||||
November 1 - November 30, 2021 | — | — | — | $ | 146,665 | |||||||||||||||||||||
December 1 - December 31, 2021 | 18,403 | 74.87 | 18,403 | $ | 145,286 | |||||||||||||||||||||
Total | 18,403 | $ | 74.87 | 18,403 |
Exhibit No. | Description of Exhibit | |||||||
v | ||||||||
v | ||||||||
Φ | ||||||||
101.INS | v | XBRL Instance Document. | ||||||
101.SCH | v | XBRL Taxonomy Extension Schema Document. | ||||||
101.CAL | v | XBRL Taxonomy Calculation Linkbase Document. | ||||||
101.DEF | v | XBRL Taxonomy Definition Linkbase Document. | ||||||
101.LAB | v | XBRL Taxonomy Label Linkbase Document. | ||||||
101.PRE | v | XBRL Taxonomy Presentation Linkbase Document. | ||||||
104 | v | Cover Page Interactive Data File. (formatted as Inline XBRL tags and contained in Exhibit 101) |
v | Filed herewith. | ||||
Φ | Furnished herewith. |
Maximus, Inc. | |||||||||||
/s/ Bruce L. Caswell | February 3, 2022 | ||||||||||
By: | Bruce L. Caswell | ||||||||||
President and Chief Executive Officer | |||||||||||
(Principal Executive Officer) | |||||||||||
/s/ David. W. Mutryn | February 3, 2022 | ||||||||||
By: | David W. Mutryn | ||||||||||
Chief Financial Officer | |||||||||||
(Principal Financial Officer) |
/s/ Bruce L. Caswell | February 3, 2022 | ||||||||||
By: | Bruce L. Caswell | ||||||||||
President and Chief Executive Officer | |||||||||||
(Principal Executive Officer) |
/s/ David W. Mutryn | February 3, 2022 | ||||||||||
By: | David W. Mutryn | ||||||||||
Chief Financial Officer | |||||||||||
(Principal Financial Officer) |
/s/ Bruce L. Caswell | February 3, 2022 | ||||||||||
By: | Bruce L. Caswell | ||||||||||
President and Chief Executive Officer | |||||||||||
(Principal Executive Officer) | |||||||||||
/s/ David W. Mutryn | February 3, 2022 | ||||||||||
By: | David W. Mutryn | ||||||||||
Chief Financial Officer | |||||||||||
(Principal Financial Officer) |
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end
Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands |
3 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Income Statement [Abstract] | ||
Revenue | $ 1,150,876 | $ 945,554 |
Cost of revenue | 922,721 | 739,499 |
Gross profit | 228,155 | 206,055 |
Selling, general, and administrative expenses | 124,221 | 111,967 |
Amortization of intangible assets | 22,405 | 6,516 |
Operating income | 81,529 | 87,572 |
Interest expense | (9,638) | (206) |
Other expense, net | (311) | (775) |
Income before income taxes | 71,580 | 86,591 |
Provision for income taxes | 18,250 | 22,514 |
Net income | $ 53,330 | $ 64,077 |
Earnings per share: | ||
Basic (in dollars per share) | $ 0.86 | $ 1.03 |
Diluted (in dollars per share) | $ 0.85 | $ 1.03 |
Weighted average shares outstanding: | ||
Basic (in shares) | 62,262 | 62,038 |
Diluted (in shares) | 62,445 | 62,135 |
Dividends declared per share (in dollars per share) | $ 0.28 | $ 0.28 |
Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Statement of Comprehensive Income [Abstract] | ||
Net income | $ 53,330 | $ 64,077 |
Other comprehensive income, net of tax: | ||
Foreign currency translation adjustments | 459 | 6,923 |
Net gains on cash flow hedge, net of tax | 2,685 | 0 |
Other comprehensive income | 3,144 | 6,923 |
Comprehensive income | $ 56,474 | $ 71,000 |
Consolidated Balance Sheets (Parenthetical) - shares |
Dec. 31, 2021 |
Sep. 30, 2021 |
---|---|---|
Statement of Financial Position [Abstract] | ||
Common stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Common stock, shares issued (in shares) | 61,936,000 | 61,954,000 |
Common stock, shares outstanding (in shares) | 61,936,000 | 61,954,000 |
Organization |
3 Months Ended |
---|---|
Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
Organization | ORGANIZATIONMaximus, a Virginia corporation established in 1975, is a leading provider of government services worldwide. Maximus operates under its founding mission of Helping Government Serve the People®, enabling citizens around the globe to successfully engage with their governments at all levels and across a variety of health and human services programs. Maximus delivers innovative business process management and technology solutions that contribute to improved outcomes for citizens and higher levels of productivity, accuracy, accountability, and efficiency of government-sponsored programs. Maximus is a proud partner to government agencies in the United States, Australia, Canada, Italy, Saudi Arabia, Singapore, South Korea, Sweden, and the United Kingdom. |
Significant Accounting Policies |
3 Months Ended |
---|---|
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Significant Accounting Policies | SIGNIFICANT ACCOUNTING POLICIES (a)Basis of Presentation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries over which the Company has a controlling financial interest, and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the U.S. Securities and Exchange Commission, or SEC. All intercompany balances and transactions have been eliminated in consolidation. (b)Basis of Presentation for Interim Periods Certain information and footnote disclosures normally included for the annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. Management believes that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly the financial position of the Company and the results of operations and cash flows for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended September 30, 2021 included in our Annual Report on Form 10-K for the fiscal year then ended (the "2021 10-K"). The Company has continued to follow the accounting policies set forth in those financial statements. (c)Estimates The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation. We base our estimates on historical experience and expectations of the future that we believe to be reasonable. The economic and political effects of the COVID-19 global pandemic increase uncertainty, which has reduced our ability to use past results to estimate future performance. Accordingly, our estimates may be subject to greater volatility than has been the case in the past.
|
Business Segments |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Segments | BUSINESS SEGMENTS We conduct our operations through three business segments: U.S. Services, U.S. Federal Services, and Outside the U.S. U.S. Services Our U.S. Services Segment provides a variety of business process services ("BPS") such as program administration, appeals and assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Addressing societal macro trends such as aging populations and rising costs, the segment continues to execute on its clinical evolution strategy by expanding its clinical offerings in public health with new work in contact tracing, disease investigation, and vaccine distribution support services as part of the governments' COVID-19 response efforts. The segment also successfully expanded into the unemployment insurance market, supporting more than 15 states in their unemployment insurance programs. U.S. Federal Services From technology solutions to program administration and operations, our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. Federal Government Agencies better deliver on their mission. This also includes appeals and assessments services, system and application development, IT modernization, and maintenance services. The segment also contains certain state-based assessments and appeals work that is part of the segment's heritage within the Medicare Appeals portfolio which continues to be managed within this segment. Benefiting from the Maximus Federal Consulting (formerly Attain Federal) platform, the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions with the acquisition of VES which manages the clinical evaluation process for U.S. veterans and service members on behalf of the U.S. Department of Veterans Affairs. The segment further supports clinical offerings in public health with new work supporting the U.S. Federal Government's COVID-19 response efforts. This included expanded work with the Centers for Disease Control and Prevention ("CDC") for their helpline and increased support for the IRS Wage and Investment Division's response efforts to general inquiries regarding the Coronavirus Aid Relief & Economic Security ("CARES") Act and Economic Impact Payment Service Plan. Outside the U.S. Our Outside the U.S. Segment provides BPS for international governments and commercial clients, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker related services. We support programs and deliver services in the U.K., including the Health Assessment Advisory Service ("HAAS"), the Work & Health Programme, Fair Start, and Restart; Australia, including jobactive and the Disability Employment Service; Canada, including Health Insurance British Columbia and the Employment Program of British Columbia; in addition to Italy, Saudi Arabia, Singapore, South Korea, and Sweden, where we predominantly provide employment support and job seeker services.
(1)Expenses that are not specifically included in the segments are included in other categories, including amortization of intangible assets and the direct costs of acquisitions. These costs are excluded from measuring each segment's operating performance. (2)Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM." (3)Other selling, general, and administrative expenses includes costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed.
|
Revenue Recognition |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue Recognition | REVENUE RECOGNITION The Company recognizes revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations which are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. Disaggregation of Revenue In addition to our segment reporting, we disaggregate our revenues by contract type, customer type, and geography. Our operating segments represent the manner in which our Chief Executive Officer reviews our financial results, which is further discussed in "Note 3. Business Segments."
Contract balances Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue. In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month. These balances are considered collectible and are included within accounts receivable — billed and billable. Exceptions to this pattern will arise for various reasons, including those listed below. •Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs which may vary over time. We typically invoice our customers at an agreed provisional billing rate which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability. •Certain contracts include retainage balances, whereby revenue is earned but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable — unbilled until restrictions on billing are lifted. As of December 31, 2021 and September 30, 2021, $12.5 million and $10.4 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions. •In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation which is distinct from the service that is subsequently provided and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred. •Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for desired outcomes, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery. During the three months ended December 31, 2021, we recognized revenue of $41.2 million included in our deferred revenue balances as of September 30, 2021. During the three months ended December 31, 2020, we recognized revenue of $14.0 million included in our deferred revenue balances at September 30, 2020. Contract estimates We are required to use estimates in recognizing revenue from some of our contracts. As discussed in "Note 2. Significant Accounting Policies," the calculation of these estimates has been complicated by the COVID-19 pandemic, which has reduced our ability to use past results to estimate future performance. Some of our performance-based contract revenue is recognized based upon future outcomes defined in each contract. This is the case in many of our employment services contracts in the Outside the U.S. Segment, where we are paid as individuals attain employment goals, which may take many months to achieve. We recognize revenue on these contracts over the period of performance. Our estimates vary from contract to contract but may include estimates of the number of participants, the length of the contract, and the participants reaching employment milestones. We are required to estimate these outcome fees ahead of their collection and recognize this estimated fee over the period of delivery. Changes to our estimates are recognized on a cumulative catch-up basis. For the three months ended December 31, 2021, we reported a reduction in revenue and diluted earnings per share of $4.7 million and $0.05, respectively, from changes in estimates. The corresponding change for the three months ended December 31, 2020, was a benefit to revenue and diluted earnings per share of $10.2 million and $0.12, respectively. Remaining performance obligations As of December 31, 2021, we had approximately $570 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 50% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration which is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.
|
Earnings Per Share |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share | EARNINGS PER SHARE
The diluted earnings per share calculation for the three months December 31, 2021 and 2020, excludes approximately 135,490 and 595,000 unvested anti-dilutive stock units, respectively.
|
Business Combinations |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination and Asset Acquisition [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combinations | BUSINESS COMBINATIONS VES Group, Inc. (VES) On May 28, 2021, the Company acquired 100% of VES for an estimated cash purchase price of $1.36 billion (the "VES Acquisition"). The final purchase price is subject to adjustment and is expected to be finalized during 2022. This business was integrated into our U.S. Federal Services Segment and is expected to increase revenue attributable to providing independent and conflict-free clinical business process services ("BPS"). The VES Acquisition also supports our ongoing strategic priority of expansion into the U.S. Federal market and accelerates our clinical evolution to meet long-term demand for BPS with a clinical dimension. As of December 31, 2021, we have completed our assessment of all acquired assets and liabilities assumed, except income taxes and working capital true-up.
Goodwill represents the value of the assembled workforce and the enhanced knowledge, capabilities, and qualifications held by the business. This goodwill balance is not deductible for tax purposes. Our evaluation of the intangible assets acquired with VES identified three assets. The assets were valued using methods which required a number of estimates and, accordingly, they are considered Level 3 measurements within the Accounting Standard Codification No. 820 (ASC 820) fair value methodology. •Customer relationships represent the value of the existing contractual relationships with the United States Federal Government. These were valued using the excess earnings method, which required us to utilize estimated future revenues and earnings from contracts and an appropriate rate of return. •VES maintains a provider network of third-party providers that assist in the performance of their clinical services. This network was valued using the cost method and income approach, which included both the cost of recreating such a network and the profits foregone during the time which would be required to recreate the network and an appropriate rate of return. •VES maintained proprietary technology which interacted with U.S. Federal Government systems, facilitated the transmission of examination data, and supported the performance of the contracts. We valued the technology using a relief-from-royalty method, which required us to estimate future revenues and an arm's length royalty rate that a third-party provider might use to supply this service and an appropriate rate of return.
In connection with certain liabilities acquired in the VES acquisition, we established a liability of $12.0 million for a billing dispute between VES and its customer relating to prior year billings. Our exposure is partially offset by an indemnification asset of $6.0 million. During the first quarter of fiscal year 2022, the liability has been agreed as $12.0 million. We expect to settle the liability in the second quarter of fiscal year 2022 and recover the indemnification balance from the escrow fund. In addition, we have established a tax liability of $12.3 million for uncertain tax positions within VES, partially offset by another indemnification asset of $7.2 million. Connect Assist Holdings Limited ("Connect Assist") On September 14, 2021, we acquired 100% of the share capital of Connect Assist for an estimated purchase price of $21.1 million (£15.5 million British Pounds). We acquired this business to improve our contact center services and qualifications within the United Kingdom. The business was integrated into our Outside the U.S. Segment. We have completed a preliminary assessment of all acquired assets and liabilities assumed. We recorded estimated goodwill and intangible assets of $11.3 million and $7.7 million, respectively, related to the acquisition. During the three months ended December 31, 2021, we reported $5.8 million and $2.2 million of revenue and gross profit, respectively, from Connect Assist. Aidvantage On October 6, 2021, we completed the acquisition of the student loan servicing business from Navient, rebranded as Aidvantage. The purchase price consideration is contingent upon future operating performance, up to a maximum payment of $65.0 million. At this time, we estimate that total payments will total approximately $15.3 million; this will increase if the number of student loans we are servicing increases or if the contractual relationship we have acquired is extended beyond its current anticipated end date of December 31, 2023. In the event that our anticipated future expense exceeds $15.3 million, we will record any difference as a charge to our statement of operating income. We recorded intangible assets related to the customer relationship of $14.9 million, which we are amortizing over 27 months. This business is a part of our U.S. Federal Services Segment and supplements our existing portfolio of services to the U.S. Department of Education. We are still in the process of completing our valuation of the assets acquired and the contingent consideration. During the three months ended December 31, 2021, we reported $34.7 million and $2.0 million of revenue and gross profit, respectively, from Aidvantage.
|
Debt |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt | DEBT
On May 28, 2021, we entered into a credit agreement with JPMorgan Chase Bank, N.A., as Administrative Agent ("Credit Agreement"), which replaced our existing revolving credit facility. The Credit Agreement provided for the following three components. •$1.10 billion term loan facility ("Term Loan A") which matures on May 28, 2026; •$400.0 million term loan facility ("Term Loan B") which matures May 28, 2028; and •$600.0 million revolving credit facility ("Revolver") which matures May 28, 2026. The interest rates applicable to loans under the Credit Agreement are floating rates based upon the London Interbank Offered Rate ("LIBOR") plus a margin. Term Loan A and the Revolver margins are dependent upon our leverage ratio. Term Loan B is set to LIBOR plus 2.00% subject to a floor of 0.50%. At execution of the Credit Agreement, the interest rates for Term Loan A and the Revolver was LIBOR plus 1.75%. During the first quarter of fiscal quarter 2022, we were able to lower our interest rates on both Term Loan A and the Revolver to LIBOR plus 1.50% based on the attainment of a total leverage ratio of 2.50 or better. As of December 31, 2021 the net total leverage ratio was 2.47. If the Company is able to achieve a net total leverage ratio of 2.00, the interest rates for Term Loan A and the Revolver could be further lowered to LIBOR plus 1.375%, conversely if the net leverage ratio increases to 2.50 or greater, the rate would revert back to LIBOR plus 1.75%. LIBOR is anticipated to be phased out over the next 18 months, and alternative benchmark rates have been identified in this agreement. This is the only significant arrangement within the Company that utilizes LIBOR. As of December 31, 2021, the annual effective interest rate, including original issue discount and amortization of debt issuance costs, was 2.3%. The Credit Agreement is available for general corporate purposes, including the funding of working capital, capital expenditures, and possible future acquisitions. In addition to borrowings, it allows us to continue to issue letters of credit when necessary. As of December 31, 2021, the Company had $100.0 million outstanding balance on the corporate Revolver. Under the terms of the Credit Agreement, the Company is required to comply with certain covenants, the terms of which are customary and include a net total leverage ratio and a net interest coverage ratio. The net total leverage ratio is calculated as total outstanding debt and contingent consideration liabilities less the lower of (a) unrestricted cash or (b) $75.0 million. With certain exceptions, the covenant requires the net total leverage ratio, as defined by the Credit Agreement to be less than 4.0, calculated over the previous twelve months. The net interest coverage ratio is calculated as earnings before interest, depreciation, and amortization ("EBITDA") divided by interest expense, over the previous twelve months, all defined by the Credit Agreement. The covenant requires a net interest coverage ratio of 3.0 or greater. As of December 31, 2021, as defined by the Credit Agreement, the Company calculated a net total leverage ratio of 2.47 and net interest coverage ratio of 16.4. The Company was in compliance with all applicable covenants under the Credit Agreement as of December 31, 2021 and September 30, 2021. We do not believe that the covenants represent a significant restriction to our ability to successfully operate the business or to pay our dividends. Costs incurred in establishing the Credit Agreement have been reported as a reduction to the gross debt balance and will be amortized over the respective lives of the arrangements. In addition to the corporate Credit Agreement, we hold smaller credit facilities in Australia and the United Kingdom. These allow our businesses to borrow to meet any short-term working capital needs.
|
Derivatives |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivatives | DERIVATIVES Interest Rate Derivative Instrument In June 2021, the Company entered into an interest rate swap agreement for a notional amount of $300.0 million, effective June 28, 2021, with an expiration date of May 28, 2026, which hedges the floating LIBOR on a portion of the term loan (Term Loan A, $1.10 billion balance) under the Credit Agreement to a fixed rate of 0.986%. The Company elected to designate this interest rate swap as a cash flow hedge for accounting purposes. As this cash flow hedge is considered effective, any future gains and losses are reflected within Accumulated Other Comprehensive Income in the Consolidated Statements of Comprehensive Income. Derivatives in a net asset position are recorded in "Prepaid expenses and other current assets" on our Consolidated Balance Sheets and derivatives in a net liability position are recorded in "Other current liabilities" on our Consolidated Balance Sheets. No ineffectiveness was recorded on this contract during the three months ended December 31, 2021.
(1)Amount is net of tax expense of $0.8 million for the three months ended December 31, 2021. (2)Amount is net of tax benefit for $0.2 million for the three months ended December 31, 2021. Counterparty Risk The Company is exposed to credit losses in the event of nonperformance by the counterparty to our derivative instrument. Our counterparty has investment grade credit ratings; accordingly, we anticipate that the counterparty will be able to fully satisfy its obligations under the contracts. Our agreements outline the conditions upon which it or the counterparty are required to post collateral. As of December 31, 2021, there was no collateral posted with its counterparty related to the derivatives.
|
Fair Value |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value | FAIR VALUE The Company had two assets recorded at fair value on a recurring basis as of December 31, 2021, the deferred compensation asset, related to the portion invested in mutual funds and the interest rate swap. For the deferred compensation asset, the mutual funds prices are quoted in active markets and therefore are classified as Level 1. For the interest rate swap, the Company obtains its Level 2 pricing inputs from its counterparty for the interest rate swap. Substantially all of these assumptions are observable in the marketplace throughout the full term of the instrument, can be derived from observable data, or are supported by observable levels at which transactions are executed in the marketplace. As of December 31, 2021, the Company had one liability recorded at fair value on a recurring basis for contingent consideration related to acquisitions. The contingent consideration liability is considered Level 3, as the inputs are not observable and based on internal assumptions about forecasted revenues, margins, volumes, and probability of contract extensions on businesses acquired. The fair values of receivables, prepaids, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of debt was $1.59 billion and $1.51 billion as of December 31, 2021 and September 30, 2021, respectively, approximates the fair value as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
|
Equity |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Equity | EQUITY Stock Compensation The Company grants restricted stock units ("RSUs") and performance stock units ("PSUs") to eligible participants under its 2017 Stock Incentive Plan, which was approved by the Board of Directors and stockholders. The RSUs granted to employees vest ratably over to five years and one year for members of the board of directors, in each case from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three year-performance period. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant. During the three months ended December 31, 2021, we issued approximately 287,000 RSUs, which will vest ratably over or four years, and approximately 87,000 PSUs, which will vest ratably over three years. Accumulated Other Comprehensive Income
Stock Repurchase Programs Under a resolution adopted in March 2020, the Board of Directors authorized the purchase, at management's discretion, of up to $200.0 million of our common stock. This supplemented a similar resolution adopted in June 2018. During the three months ended December 31, 2021 and 2020, the Company purchased 18,403 and 51,735 common shares at a cost of $1.4 million and $3.4 million, respectively. As of December 31, 2021, $145.3 million remained available for future stock repurchases.
|
Cash And Cash Equivalents And Restricted Cash |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash And Cash Equivalents And Restricted Cash | CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
(1)Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
|
Accounts Receivable, Net |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Accounts Receivable, Net | ACCOUNTS RECEIVABLE, NET
|
Property And Equipment, Net |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property And Equipment, Net | PROPERTY AND EQUIPMENT, NET
As of December 31, 2021, we classified as held for sale one building and the associated land with a carrying value of $5.4 million within "Prepaid expenses and other current assets" on our Consolidated Balance Sheets. As of December 31, 2021, we concluded the fair value less the costs to sell exceeds the carrying value of this asset.
|
Commitments and contingencies |
3 Months Ended |
---|---|
Dec. 31, 2021 | |
Commitments and Contingencies Disclosure [Abstract] | |
Commitments And Contingencies | COMMITMENTS AND CONTINGENCIES Litigation We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments, and otherwise in connection with performing services in countries outside of the U.S. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business. These include but are not limited to bid protests, employment matters, contractual disputes, and charges before administrative agencies. Although we can give no assurance, based upon our evaluation and taking into account the advice of legal counsel, we do not believe that the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows. Medicaid claims The Centers for Medicare and Medicaid Services (CMS) asserted two disallowances against a state Medicaid agency. The state contested the first disallowance and ultimately settled that claim for approximately $7.3 million. The second disallowance of approximately $19.9 million is still being contested by the state. The state is seeking reimbursement from us for the first disallowance of $7.3 million and has indicated its intention to seek reimbursement of the second disallowance if its legal challenge is unsuccessful. From 2004 through 2009, we had a contract with the state agency in support of its school-based Medicaid claims. We entered into separate agreements with the school districts under which we assisted the districts with preparing and submitting claims to the state Medicaid agency which, in turn, submitted claims for reimbursement to CMS. The state has asserted that its agreement with us requires us to reimburse the state for the amounts owed to CMS. However, our agreements with the school districts require them to reimburse us for such amounts, and therefore we believe the school districts are responsible for any amounts that ultimately must be refunded to CMS. Although it is reasonably possible that a court could conclude we are responsible for the full balance of the disallowances, we believe our exposure in this matter is limited to our fees associated with this work and that the school districts will be responsible for the remainder. We have recorded a liability of our estimated fees earned from this engagement relating to the disallowances. We exited the federal healthcare-claiming business in 2009 and no longer provide the services at issue in this matter.
|
Subsequent Event |
3 Months Ended |
---|---|
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
Subsequent Event | SUBSEQUENT EVENTOn January 7, 2022, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on February 28, 2022, to shareholders of record on February 15, 2022. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $17.3 million. |
Significant Accounting Policies (Policies) |
3 Months Ended |
---|---|
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of Presentation | Basis of Presentation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries over which the Company has a controlling financial interest, and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the U.S. Securities and Exchange Commission, or SEC. All intercompany balances and transactions have been eliminated in consolidation. (b)Basis of Presentation for Interim Periods Certain information and footnote disclosures normally included for the annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. Management believes that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly the financial position of the Company and the results of operations and cash flows for the periods presented. The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the notes thereto for the year ended September 30, 2021 included in our Annual Report on Form 10-K for the fiscal year then ended (the "2021 10-K"). The Company has continued to follow the accounting policies set forth in those financial statements.
|
Estimates | Estimates The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of goodwill, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation. We base our estimates on historical experience and expectations of the future that we believe to be reasonable. The economic and political effects of the COVID-19 global pandemic increase uncertainty, which has reduced our ability to use past results to estimate future performance. Accordingly, our estimates may be subject to greater volatility than has been the case in the past.
|
Business Segments (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Segment Reporting [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of financial information for each of the Company's business segments |
(1)Expenses that are not specifically included in the segments are included in other categories, including amortization of intangible assets and the direct costs of acquisitions. These costs are excluded from measuring each segment's operating performance. (2)Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM." (3)Other selling, general, and administrative expenses includes costs that are not allocated to a particular segment. This includes expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed.
|
Revenue Recognition (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Revenue from Contract with Customer [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Disaggregation of Revenue |
|
Earnings Per Share (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Earnings Per Share [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Weighted average number of shares used to compute earnings per share |
|
Business Combinations (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Combination and Asset Acquisition [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Acquired Finite-Lived Intangible Assets Weighted Average Remaining Lives |
|
Debt (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Debt |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Maturities of Long-term Debt |
|
Derivatives (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Derivative Instruments and Hedging Activities Disclosure [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Assets at Fair Value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Derivative Liabilities at Fair Value |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Losses on Derivatives |
(1)Amount is net of tax expense of $0.8 million for the three months ended December 31, 2021. (2)Amount is net of tax benefit for $0.2 million for the three months ended December 31, 2021.
|
Fair Value (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fair Value Disclosures [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Fair Value of Assets and Liabilities |
|
Equity (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Share-based Payment Arrangement [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Changes in Accumulated Other Comprehensive Loss by Category | Accumulated Other Comprehensive Income
|
Cash And Cash Equivalents And Restricted Cash (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of Cash and Cash Equivalents |
(1)Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Restrictions on Cash and Cash Equivalents |
(1)Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Supplementary Cash Flow Information |
|
Accounts Receivable, Net (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Receivables [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Details of Accounts Receivable |
|
Property And Equipment, Net (Tables) |
3 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Dec. 31, 2021 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Property, Plant and Equipment [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Schedule of property, plant and equipment |
|
Revenue Recognition - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions |
3 Months Ended | ||
---|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
Sep. 30, 2021 |
|
Disaggregation of Revenue [Line Items] | |||
Deferred revenue, revenue recognized | $ 41.2 | $ 14.0 | |
Cumulative catch-up adjustment to revenue from change in estimates | $ (4.7) | $ 10.2 | |
Cumulative catch-up adjustment to diluted earnings per share from change in estimates (in dollars per share) | $ 0.05 | $ 0.12 | |
Unbilled receivables | |||
Disaggregation of Revenue [Line Items] | |||
Unbilled contracts receivable | $ 12.5 | $ 10.4 |
Revenue Recognition - Remaining Performance Obligation (Details) $ in Millions |
Dec. 31, 2021
USD ($)
|
---|---|
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, amount | $ 570 |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-01-01 | |
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] | |
Revenue, remaining performance obligation, percentage | 50.00% |
Revenue, remaining performance obligation, expected timing of satisfaction, period | 12 months |
Earnings Per Share (Details) - shares |
3 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Earnings Per Share [Abstract] | ||
Basic weighted average shares outstanding (in shares) | 62,262,000 | 62,038,000 |
Dilutive effect of unvested RSUs and PSUs (in shares) | 183,000 | 97,000 |
Denominator for diluted earnings per share (in shares) | 62,445,000 | 62,135,000 |
Antidilutive securities excluded from computation of earnings per share (in shares) | 135,490 | 595,000 |
Business combinations - Schedule of the Valuation of the Intangible Assets Acquired (Details) - VES Group, Inc. $ in Thousands |
May 28, 2021
USD ($)
|
---|---|
Finite-Lived Intangible Assets [Line Items] | |
Estimated Fair Value | $ 664,000 |
Customer contracts and relationships | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Straight-Line Useful Life | 12 years |
Estimated Fair Value | $ 580,000 |
Provider network | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Straight-Line Useful Life | 12 years |
Estimated Fair Value | $ 57,000 |
Technology-based intangible assets | |
Finite-Lived Intangible Assets [Line Items] | |
Estimated Straight-Line Useful Life | 12 years |
Estimated Fair Value | $ 27,000 |
Debt - Schedule of Debt (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Sep. 30, 2021 |
---|---|---|
Debt Instrument [Line Items] | ||
Total debt principal | $ 1,607,064 | $ 1,523,531 |
Less: Unamortized debt-issuance costs and discounts | (13,272) | (13,839) |
Total debt | 1,593,792 | 1,509,692 |
Less: Current portion of long-term debt | (78,703) | (80,555) |
Long-term debt | 1,515,089 | 1,429,137 |
Secured Debt | Term Loan A, due 2026 | ||
Debt Instrument [Line Items] | ||
Total debt principal | 1,072,500 | 1,086,250 |
Secured Debt | Term Loan B, due 2028 | ||
Debt Instrument [Line Items] | ||
Total debt principal | 398,000 | 399,000 |
Subsidiary Loans | ||
Debt Instrument [Line Items] | ||
Total debt principal | 36,564 | 38,281 |
Line of Credit | Revolver | ||
Debt Instrument [Line Items] | ||
Total debt principal | 100,000 | $ 0 |
Total debt | $ 100,000 |
Debt - Schedule of Repayments (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Sep. 30, 2021 |
---|---|---|
Debt Disclosure [Abstract] | ||
January 1, 2022 through September 30, 2022 | $ 65,035 | |
Year ended September 30, 2023 | 72,927 | |
Year ended September 30, 2024 | 93,482 | |
Year ended September 30, 2025 | 95,120 | |
Year ended September 30, 2026 | 901,500 | |
Thereafter | 379,000 | |
Total payments | $ 1,607,064 | $ 1,523,531 |
Derivatives - Narrative (Details) - USD ($) |
Jun. 28, 2021 |
May 28, 2021 |
---|---|---|
Five Year Term Loan | Secured Debt | ||
Derivative [Line Items] | ||
Debt instrument, face amount | $ 1,100,000,000 | |
Interest rate swap | ||
Derivative [Line Items] | ||
Derivative, notional amount | $ 300,000,000 | |
Derivative, fixed interest rate | 0.986% |
Derivatives - Schedule of Derivative Fair Value (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Sep. 30, 2021 |
---|---|---|
Derivatives, Fair Value [Line Items] | ||
Total assets | $ 3,233 | $ 0 |
Total liabilities | 0 | 410 |
Interest rate swap | ||
Derivatives, Fair Value [Line Items] | ||
Total assets | 3,233 | 0 |
Total liabilities | $ 0 | $ 410 |
Derivatives - Schedule of Losses on Derivatives (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Derivative [Line Items] | ||
Other comprehensive income | $ 3,144 | $ 6,923 |
Net unrealized (loss)/gain on derivatives, net of tax | ||
Derivative [Line Items] | ||
Net gains recognized in AOCI on derivatives, net of tax | 2,177 | 0 |
Amounts reclassified to earnings from accumulated other comprehensive loss | 508 | 0 |
Other comprehensive income | 2,685 | $ 0 |
Tax expense | 800 | |
Tax benefit | $ 200 |
Cash And Cash Equivalents And Restricted Cash - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Sep. 30, 2021 |
Dec. 31, 2020 |
Sep. 30, 2020 |
---|---|---|---|---|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||||
Cash and cash equivalents | $ 181,790 | $ 135,061 | ||
Restricted cash | 20,822 | 21,509 | ||
Cash, cash equivalents, and restricted cash | $ 202,612 | $ 156,570 | $ 149,818 | $ 88,561 |
Cash And Cash Equivalents And Restricted Cash - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands |
3 Months Ended | |
---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract] | ||
Interest payments | $ 8,943 | $ 203 |
Income tax payments | $ 8,009 | $ 4,093 |
Accounts Receivable, Net (Details) - USD ($) $ in Thousands |
Dec. 31, 2021 |
Sep. 30, 2021 |
---|---|---|
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Allowance for credit losses | $ (7,742) | $ (8,044) |
Accounts receivable, net | 849,410 | 834,819 |
Billed and billable receivables | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts Receivable Gross | 717,804 | 718,728 |
Unbilled receivables | ||
Accounts, Notes, Loans and Financing Receivable [Line Items] | ||
Accounts Receivable Gross | $ 139,348 | $ 124,135 |
Property And Equipment, Net (Details) $ in Thousands |
Dec. 31, 2021
USD ($)
building
|
Sep. 30, 2021
USD ($)
|
---|---|---|
Property, Plant and Equipment [Line Items] | ||
Property and equipment, at cost | $ 324,723 | $ 347,759 |
Accumulated depreciation | (271,096) | (285,132) |
Property and equipment, net | $ 53,627 | 62,627 |
Number of buildings classified as held for sale | building | 1 | |
Prepaid Expenses and Other Current Assets | Building | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, net | $ 5,400 | |
Land | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, at cost | 0 | 1,738 |
Building and improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, at cost | 0 | 11,981 |
Office furniture and equipment | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, at cost | 245,110 | 254,102 |
Leasehold improvements | ||
Property, Plant and Equipment [Line Items] | ||
Property and equipment, at cost | $ 79,613 | $ 79,938 |
Commitments and contingencies - Narrative (Details) $ in Millions |
Dec. 31, 2021
USD ($)
disallowance
|
---|---|
Loss Contingencies [Line Items] | |
Number of disallowances | disallowance | 2 |
Settled Litigation | |
Loss Contingencies [Line Items] | |
Disallowance | $ 7.3 |
Pending Litigation | |
Loss Contingencies [Line Items] | |
Disallowance | $ 19.9 |
Subsequent Event (Details) - USD ($) $ / shares in Units, $ in Millions |
Feb. 28, 2022 |
Jan. 07, 2022 |
---|---|---|
Subsequent Event | ||
Subsequent Event [Line Items] | ||
Cash dividend declared (in dollars per share) | $ 0.28 | |
Common Stock | Forecast | ||
Subsequent Event [Line Items] | ||
Payments of dividends | $ 17.3 |
NZG5X/(V0E(6M"
M. H"*!30/_L#\@#/D>^R.G>X).WU*7D41BLRAC:#T=YHJ.P8;NG;U/M?N&-[
M!MW]JC:R$A67>Q%0CR5&5MH_Q0W\(UDQ$B=:K4/I5V<2U\1'85D3*.[D']$F
M*C$\(G^&J].?!Z[(7-IW,;:R.E#02@79+J+9RJJY*NI#H]3;(Y9U@2&
MN_8A1>1VZR^YA"GPJ6I5(_3T-KW%B,H"P!H5@'&JM9UGY).++%=@#VGES+Q&
M\>WC?/X]66G\K)'QWUN#SI=>=EKZB59+AB#5GI\:R1Q]L9$-1Q<-&%TI6C
MOD;G@6L8 2/?AR4FS ]$D$MBC*7;LT9N/XUY%!WU*GQH*RZK87'!NNDC*]V>
M-7+[VUCHA67Z%13,$D7#!6O12K-GN%[_QQ
MFBV:R??40)F4F;-]#N5^+?VE =X&4NW%65MXRT,7I16QXKV/@O'TX58ZRPCG(Z([HC.#] ;
M/1^+3UA/(6MV2$([./_Z=SBDJ(R0R>^P;SAXQ8K 2W57XAWNQ]MU0T/_@>>D
MMKK8D#@1D6=8OKK71"%Y7:6.8&D2,J)BVEV!1IIN/J.+5*
MB1C*TS%N[7C$R9C^NI:-H]'Y]4T+U0&"0F;. *>R-+9R+(LI-H;N);.$I#HF
M/(W5U3UI!4)('R19>-+*GO (ME^49U3&,>(A$?&$.U;5SF0UWPX*.26##)<>
M5\KFB'$YG24C =>(3]56R/YH%Z/'\"7B!ZZK\K6RG?L&XE:)K=P!&EAAI@AP
MNEW"]9QC?>"8S++>.ND5A*=[,RUA<8 &/&.YSE420.98E17IS.10CKQ3?C.E
M $(JEJ6NP%QE:W5 V9W
M3P,"'5^P+<)=JQ%/*@2D+_8;2OJ@\5]V8G@O),'5:+BLS0>X1NUG@:SPH^N'
M&MX!6\3A(I_3*EUDX6(>$P-C/P[=:"!C<1B7"60E"UF9P95X),R@1860Y$F8
MQSDD:1P610%WU.] 8>B$6]2"=P:2>1EF&8.$S?WS3EG>T3B8$#&YF$') LT*A#)@5))FH"\@@621]$0?7
M4-=!O_A\#@XR0^9EQJU4"7M(V\K*.Q12T(A^8O>BV6FD-\"UC:PKKL)Q\K7E
M&&+[G
M2?2CA0\^\<%N/G1;U"HX6:)'9E>PN3OZ#,_80.3#&"8G,D?6)BZ . DTV-*$
M37T4XG@(6YFP*/+\)+9GP#]EP&_M\$@&/M:I[,I<;LF2'J_>C)6)8_^#TVJ!
M,]]_2+THZI15U);7P-QEWXLB+0^74 -BX8E8Z"0F6[5LQ+7L4TU#Z_09B(;4
M7):4E ;U= DD2"L;>P%T(!H="(:.8DN",_!1HHBR&FVI6]!+5,J6YP@3S:>
MD4%AI&+BT_KQY?6SXK'(Z$B#C(TEIS!"GKZ-%V$#>LF)7N*DMWQA!F0[?5A_
ML3),C$KRM,HU$1B'6@")&< Y:$ ?>KV(>>$
MK87,YDZG"W8/4G5TWEH,ID7%H@0.$(2\7NXD"/P 9/A?"5X?"1Y(7;RUB=1+
MGAU(?A8E*.CR_)3TF4-3VK";FB%H6,"K*I>)+7FD 1EN6 ,:=< >0<_!7ENL
M
4;O]HP]QT@Z,A)^'.+L=/1B.M\ODO-A#_P[O1^]
M1":#9UTMW3H^7KLO3GKA[4YW[^.K]"S
M- FGDVS03<\MUHW.2UI!L-"*>KXR<._'C+EA5J+I"JIJ%QD5Y ,C?>> LGYH
MJAJJFO;U=AI[#R$P2^>"9.UZ^\Y P4VNT7D('4)3NVD[HL-Z&-%!(H1S37+5
M^(S03+7#ZJ:4&SJDZUIX*#=&8#B9,'V ]D^-1+^K5[.56,%E[C58)JZ9OIIC4(=%T$#MN^;ZRSA$MYP>VQSNT
MGP];3:NH1REXC=)P)4%CN0A6\<4Z<_$^X'>.1W-B@ZMDI]07M_A0+(*A$X0"
M<^L0&'T>\!*%<$ DXVN'&?24+O'4?D;_U==.M>R8P4LE_N"%K1;!-( "2]8(
M>ZN.[[&K9^3P
.$9UXPXZ:3NW$0Q@[